(Q61921187)
Statements
A Double Blind, Randomised, Placebo Controlled Study Investigating Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis in Patients Treated With Copaxone for at Least 3 Months (English)
0 references
March 2008
0 references
0
0 references
18 year
0 references
60 year
0 references